| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/17/2002 | US20020006905 Use of botulinum toxins for treating various disorders and conditions and associated pain |
| 01/17/2002 | US20020006904 Somatotropin in buffer solution |
| 01/17/2002 | US20020006903 Genetic engineering |
| 01/17/2002 | US20020006902 Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction |
| 01/17/2002 | US20020006901 Prevent grafting rejection |
| 01/17/2002 | US20020006899 Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals |
| 01/17/2002 | US20020006898 Trimethyl lock based tetrapartate prodrugs |
| 01/17/2002 | US20020006897 Regulaton of cytokine synthesis and release |
| 01/17/2002 | US20020006896 Administering tissue factor pathway inhibitor |
| 01/17/2002 | US20020006895 Method of treatment of cardiovascular injuries |
| 01/17/2002 | US20020006894 Nonantigenic stabilizer and physiologically active substance |
| 01/17/2002 | US20020006893 Method of modulating cellular activity |
| 01/17/2002 | US20020006892 Serum albumin compositions for use in cleansing or dermatological products for skin or hair |
| 01/17/2002 | US20020006656 Zcys5: a member of the cystatin superfamily |
| 01/17/2002 | US20020006655 Enzymatic polypeptide for use in infant food processing |
| 01/17/2002 | US20020006654 Isolated cathepsin L type cysteine proteases and reducing intercorneocyte cohesion/promoting desquamation therewith |
| 01/17/2002 | US20020006653 Nucleotide sequences coding enzymatic polypeptide; for use in the treatment of cancers, nervous system, cardiovascular, brain, prostatic and muscle disorder |
| 01/17/2002 | US20020006652 Nucleic acids encoding polypeptides having haloperoxidase activity |
| 01/17/2002 | US20020006649 Matrix; for use in wound healing |
| 01/17/2002 | US20020006640 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 01/17/2002 | US20020006639 Nucleotide sequences coding asthma associated protein; for use in the diagnosis and treatment of genetic disorders associated with inflammation and air passage blockage |
| 01/17/2002 | US20020006430 Angiotensin converting enzyme (ACE) inhibitor; controlled release diltiazem in the core in combination with a rapid release ACE inhibitor, or diuretic, in an external coat; pharmacokinetics; easier to swallow; treating hypertension |
| 01/17/2002 | US20020006410 Method for treating inflammatory diseases using heat shock proteins |
| 01/17/2002 | US20020006408 Vaccines against eimeria mediated disorder |
| 01/17/2002 | US20020006407 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
| 01/17/2002 | US20020006406 Lysostaphin an anti-staphylococcal agent for parenteral administration to mammals including humans exhibits the biological activity of proteolytic attack against glycincontaining bridges in the cell wall peptidoglycan of |
| 01/17/2002 | US20020006401 Administering systemically or at the site of the injury to vascular tissue in a region of the blood vessel of the patient a compound which reduces/inhibit leukocyte integrin mediated adhesion to reduce stenosis or dependent restenosis |
| 01/17/2002 | US20020006400 Recombinant human CLN2 protein and methods of its production and use |
| 01/17/2002 | US20020006399 Therapeutic uses of hormonal manipulation using combinations of various agents to treat atherosclerosis |
| 01/17/2002 | US20020006396 Method of treating portal hypertension |
| 01/17/2002 | US20020006391 Genetic engineering |
| 01/17/2002 | US20020006383 Promoter of biosynthesis of skin cells |
| 01/17/2002 | DE10031744A1 Mit Blutplasma verträgliche, vernetzte und mit Polyalkylenoxiden konjugierte Säugetierhämoglobine als künstliche medizinische Sauerstoffträger, ihre Herstellung und ihre Verwendung With blood plasma compatible, networked and conjugated with polyalkylene oxides mammalian hemoglobins as artificial medical oxygen carriers, their preparation and their use |
| 01/17/2002 | DE10031742A1 Production of cross-linked hemoglobin useful as artificial oxygen carrier comprises cross-linkage of hemoglobin in presence of a chemically inert effector of the hemoglobin oxygen affinity |
| 01/17/2002 | DE10031741A1 Externally applied oxygen carrier preparation for treating oxygen deficiency states of the skin, comprises active agent, specifically hemoglobin or its mixture with myoglobin, incorporated in a gel carrier |
| 01/17/2002 | CA2658217A1 Expression system |
| 01/17/2002 | CA2427066A1 Method for the recovery and application of human defensins as biologically active proteins for the treatment of infections and other diseases |
| 01/17/2002 | CA2415967A1 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip) |
| 01/17/2002 | CA2415808A1 Transporters and ion channels |
| 01/17/2002 | CA2415778A1 Methods of therapy with thrombin derived peptides |
| 01/17/2002 | CA2415569A1 Fungal cell wall synthesis gene |
| 01/17/2002 | CA2415544A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/17/2002 | CA2415483A1 Antisense compositions targeted to .beta.1 adrenoceptor-specific mrna and methods of use |
| 01/17/2002 | CA2415434A1 Use of the heat shock protein gp96 |
| 01/17/2002 | CA2415425A1 Insulin derivatives and synthesis thereof |
| 01/17/2002 | CA2415422A1 Chromosome 3p21.3 genes are tumor suppressors |
| 01/17/2002 | CA2415179A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 01/17/2002 | CA2415127A1 Down syndrome critical region 1-like 1 proteins |
| 01/17/2002 | CA2415100A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications |
| 01/17/2002 | CA2415083A1 Anti-hiv and anti-tumor peptides and fragments of lysozyme |
| 01/17/2002 | CA2415080A1 Improved thyroid hormone formulations |
| 01/17/2002 | CA2414926A1 Microspheres and adjuvants for dna vaccine delivery |
| 01/17/2002 | CA2414387A1 Drug metabolizing enzymes |
| 01/17/2002 | CA2414374A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/17/2002 | CA2414219A1 Lipid metabolism molecules |
| 01/17/2002 | CA2413810A1 Aminoacyl trna synthetases |
| 01/17/2002 | CA2413045A1 Expression system |
| 01/17/2002 | CA2413035A1 Thrombin inhibitors comprising an aminoisoquinoline group |
| 01/17/2002 | CA2412764A1 Stimulation of cellular regeneration and differentiation in the inner ear |
| 01/17/2002 | CA2412581A1 Transforming growth factor beta (tgf-.beta.) blocking agent-treated stem cell composition and method |
| 01/17/2002 | CA2412162A1 Chemokine receptor modulators, production and use |
| 01/17/2002 | CA2412150A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/17/2002 | CA2412124A1 Connective tissue growth factor-2 |
| 01/17/2002 | CA2385142A1 New class of bioactive glycoprotein |
| 01/17/2002 | CA2351110A1 Helicobacter felis vaccine |
| 01/16/2002 | EP1172654A1 Diagnostic method based on the detection of the L1 adhesion molecule for ovarian and endometrial tumors |
| 01/16/2002 | EP1172377A1 Compounds and methods for inhibiting amyloid Beta-protein filament formation and neurotoxicity |
| 01/16/2002 | EP1172376A1 Peptide analogues at position 91 of human myelin basic protein for treatment of multiple sclerosis |
| 01/16/2002 | EP1172115A1 Hemostatic soluble cellulose fibers containing coagulating protein for treating wound and process for producing the same |
| 01/16/2002 | EP1172114A2 Stable concentrated insulin preparations for pulmonary delivery |
| 01/16/2002 | EP1172113A1 Remedies for autonomic neuropathy |
| 01/16/2002 | EP1172087A2 Topical treatment of skin |
| 01/16/2002 | EP1172041A2 Compositions of plant carbohydrates as dietary supplements |
| 01/16/2002 | EP1171626A1 50 human secreted proteins |
| 01/16/2002 | EP1171614A1 Dsp-4 dual-specificity map kinase phosphatase |
| 01/16/2002 | EP1171612A2 Telomerase-specific cancer vaccine |
| 01/16/2002 | EP1171607A1 Streptokinase fragments and their use for inhibiting cell death |
| 01/16/2002 | EP1171605A1 Peptides and assays for the diagnosis of lyme disease and compositions useful for the prevention thereof |
| 01/16/2002 | EP1171604A2 Dna sequence and recombinant production of a graminae allergen |
| 01/16/2002 | EP1171602A1 Anti-angiogenic intestinal peptides, zdint5 |
| 01/16/2002 | EP1171600A2 Zalpha13: a human secreted protein |
| 01/16/2002 | EP1171599A1 Adipocyte complement related protein homolog zacrp2 |
| 01/16/2002 | EP1171597A2 Prostate-restricted gene 30p3c8 expressed in prostate cancer |
| 01/16/2002 | EP1171596A1 Synthetic transmembrane components |
| 01/16/2002 | EP1171595A1 13 transmembrane protein expressed in prostate cancer |
| 01/16/2002 | EP1171594A1 Vascular endothelial cell growth factor variants and uses thereof |
| 01/16/2002 | EP1171591A1 48 human secreted proteins |
| 01/16/2002 | EP1171590A1 50 human secreted proteins |
| 01/16/2002 | EP1171589A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof |
| 01/16/2002 | EP1171586A2 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 01/16/2002 | EP1171585A1 49 human secreted proteins |
| 01/16/2002 | EP1171582A2 Long lasting anti-angiogenic peptides |
| 01/16/2002 | EP1171580A2 Human homologues of fused gene |
| 01/16/2002 | EP1171579A1 Human tumor necrosis factor receptor tr9 |
| 01/16/2002 | EP1171576A1 PSEUDOMYCIN PRODUCTION BY $i(PSEUDOMONAS SYRINGAE) |
| 01/16/2002 | EP1171573A1 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 01/16/2002 | EP1171469A1 ANTI-p53 ANTIBODIES |
| 01/16/2002 | EP1171466A2 G-protein coupled receptor and method of using same |
| 01/16/2002 | EP1171465A2 Analogs of gastric inhibitory peptide and their use for treatment of diabetes |
| 01/16/2002 | EP1171464A2 Peptide homodimers or peptide heterodimers derived from interleukin 12 |